A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

NCT00001999 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Globulin, Immune
DRUG: Ganciclovir

Sponsor

American National Red Cross